Cellular basis of diabetic nephropathy: II. The transforming growth factor-β system and diabetic nephropathy lesions in type 1 diabetes

Diabetes

Volumn 51, Issue 12, 2002, Pages 3577-3581

  Huang, Chunmei ^a   Kim, Youngki ^a   Caramori, Maria Luiza A ^a   Fish, Alfred J ^b   Rich, Stephen S ^b   Miller, Michael E ^b   Russell, Gregory B ^b   Mauer, Michael ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; MESSENGER RNA; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; HUMAN CELL; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; SKIN FIBROBLAST;

EID: 0036895640     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.12.3577     Document Type: Article

References (27)

1. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-beta as a key mediator (Review Article). Diabetes 44:1139-1146, 1995
2. Reeves WB, Andreoli TE: Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 97:7667-7669, 2000
3. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J: Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 52:354-362, 2001
4. Piek E, Heldin CH, Ten Dijke P: Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13:2105-2124, 1999
5. Oklu R, Hesketh R: The latent transforming growth factor beta binding protein (LTBP) family (Review Article). Biochem J 352 (Pt 3):601-610, 2000
6. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study. Kidney Int 50:2041-2046, 1996
7. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
8. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving H-H: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
9. Viberti G: Why do we have to invoke genetic susceptibility for diabetic nephropathy? Kidney Int 55:2526-2527, 1999
10. LaPointe MS, Batlle D: Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy. Am J Kidney Dis 38:646-648, 2001
11. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
12. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M: Cellular basis of diabetic nephropathy. I. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51:506-513, 2002
13. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
14. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
15. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, Kurnik PB, Weisberg LS: Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46:854-859, 1997
16. Miyazono K, Thyberg J, Heldin CH: Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem 267:5668-5675, 1992
17. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF: Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol 131:539-549, 1995
18. Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T, Nakamura H: Extracellular fibrillar structure of latent TGF beta binding protein-1: Role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol 136:193-204, 1997
19. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K: Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157:423-433, 2000
20. Wada T, Hamakawa S, Hori Y, Kaname S, Shimizu S, Kurokawa K, Katoh T: Immunohistochemical localization of latent transforming growth factor-beta binding protein in IgA nephropathy. Kidney Int Suppl 63:S182-S184, 1997
21. Halford WP: The essential prerequisites for quantitative RT-PCR. Nat Biotechnol 17:835, 1999
22. Lion T: Current recommendations for positive controls in RT-PCR assays. Leukemia 15:1033-1037, 2001
23. Suzuki T, Higgins PJ, Crawford DR: Control selection for RNA quantitation Biotechniques 29:332-337, 2000
24. Trevisan R, Fioretto P, Barbosa J, Mauer M: Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int 55:2383-2389, 1999
25. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res 6:986-994, 1996
26. Milliken G, Johnson DE: Analysis of Messy Data. Designed Experiments. Vol. 1. New York, Van Nostrand Reinhold, 1984
27. Sokal RR, Rohlf FJ: Biometry. 2nd ed. New York, W.H. Freeman, 1981